Inhibikase Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $81k | 50k | 1.62 |
| 2023-09-30 | $7 | 5 | 1.40 |
| 2023-06-30 | $7 | 2 | 3.50 |